Management of refractory and resistant CMV: A step forward but more work needed

Transpl Infect Dis. 2021 Aug;23(4):e13704. doi: 10.1111/tid.13704. Epub 2021 Aug 5.

Authors

Rbab Taha¹, Atul Humar¹

Affiliation

¹ Ajmera Transplant Centre, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.

PMID: 34324248
DOI: 10.1111/tid.13704

No abstract available

Publication types

Editorial

MeSH terms

Antiviral Agents / therapeutic use
Cytomegalovirus
Cytomegalovirus Infections* / drug therapy
Humans

Substances

Antiviral Agents